Why Great MSLs Determine Whether a Product Launch Succeeds

Author(s): Richard Meyer

Every pharma company says people are their greatest asset. Yet during product launches, many companies make the same expensive mistake: they hire Medical Science Liaisons who are excellent presenters but poor challengers. They hire people who execute. They need people who think and who question data that doesn’t quite line up. Hiring inexperienced MSLs could hinder your new product launch and set it back years.

Launching a new therapy isn’t just about educating healthcare professionals. It’s about discovering what the organization doesn’t yet know—and adapting before those blind spots become commercial problems. That’s why great, experienced MSLs are among the highest-return investments a launch team can make.